Phathom Pharmaceuticals Investor Relations Material
Latest events
Q4 2023
Phathom Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies
Latest reports from Phathom Pharmaceuticals Inc
Access all reports
Phathom Pharmaceuticals, Inc. (Phathom), a clinical-stage biopharmaceutical company, focuses on developing and commercializing treatments for gastrointestinal diseases. The company develops products based on its polymer-based nanoparticle delivery system that increase the absorption of bioactive molecules and improves their pharmacokinetic profiles. It also provides PhathomSTAR™ Booster Powder, a proprietary powder formulation in a capsule formulation that creates an increase in bioavailability when diluted with water or food. Phathom was incorporated in 2004 and is headquartered in Redwood City, California."
Key slides for Phathom Pharmaceuticals Inc
Investor Presentation
Phathom Pharmaceuticals Inc
Investor Presentation
Phathom Pharmaceuticals Inc
Latest articles
Daniel Ek: Co-founder and CEO of Spotify
Explore Daniel Ek's journey from a tech-savvy teenager to the co-founder and CEO of Spotify and the most influential person in the music industry.
28 Mar 2024
Companies That Had Their IPO in 1992: A Cautiously Optimistic Market
1992 marked a relatively cool IPO landscape and stock market sentiment, in the wake of the early 90s recession.
28 Mar 2024
Remembering Daniel Kahneman: Transforming Psychology and Economics
Explore Daniel Kahneman's legacy in psychology and economics, highlighting his impact on decision-making and behavioral economics.
28 Mar 2024
Ticker symbol
Country
🇺🇸 United States